Fareston

Indicated For

metastatic breast cancer

About This Medication

# Fareston Patient Assistance Program Patient Guide: How to Get Fareston (toremifene) at Low or No Cost **Important Notice: Kyowa Kirin discontinued distribution of Fareston (toremifene) in the US effective August 31, 2024.** This means the medication is no longer available through standard channels, including patient assistance programs. Existing program details are provided below for reference, but new applications are unlikely to be fulfilled. Please consult your healthcare provider immediately for alternative treatments.[10] ## About Fareston (toremifene) Fareston, known generically as **toremifene**, is a prescription medication classified as a selective estrogen receptor modulator (SERM). It was primarily used to treat advanced **metastatic breast cancer** in postmenopausal women whose tumors are estrogen-receptor positive. Toremifene works by blocking estrogen in breast tissue, slowing or stopping the growth of cancer cells. It is typically taken as a 60 mg tablet once daily, with or without food, and treatment duration depends on your doctor's recommendation and response to therapy. Common side effects include hot flashes, sweating, nausea, vaginal discharge, fatigue, and dizziness. Serious risks can involve blood clots, endometrial changes, or elevated liver enzymes—always report unusual symptoms to your doctor. Since distribution has ended, discuss switches to similar drugs like tamoxifen or other hormone therapies with your oncologist.[10] ## Who Qualifies for the Fareston Patient Assistance Program? The **Fareston Patient Assistance Program** by **Kyowa Kirin** aimed to provide free medication to eligible patients facing financial hardship. It targeted **uninsured or underinsured patients** who could not afford their prescriptions. Qualification focused on residency, income, and insurance status rather than specific medical diagnoses (beyond a valid prescription for Fareston). Key eligibility factors included: - **U.S. residency** (must live in the United States). - **Financial need**, often at or below a certain percentage of the Federal Poverty Level (FPL), though exact thresholds were not publicly detailed and required verification.[6] - **Valid prescription** from a licensed U.S. healthcare provider. - No assistance for patients with certain government insurances in co-pay programs, but PAP was for uninsured.[3][2] **Note:** With Fareston discontinued, Kyowa Kirin Cares may still offer guidance via phone, but medication fulfillment is unavailable.[10][1] ## Income Eligibility Breakdown Specific income thresholds for the Fareston PAP were not publicly listed in detail, as Kyowa Kirin verified eligibility case-by-case, often using electronic income checks or proof of income at **100% of the Federal Poverty Level (FPL)** or below, similar to other Kyowa Kirin programs.[6] Here's a general table based on 2024 FPL guidelines for reference (adjust for current year via HHS.gov; exact program cutoffs required program confirmation): | Household Size | 100% FPL (Annual Income) | Notes | |---------------|---------------------------|-------| | 1 (Individual) | $15,060 | Case-by-case verification[6] | | 2 (Couple) | $20,440 | Proof of income required | | 3 | $25,820 | Electronic or documented proof[5] | | 4 | $31,200 | Households above may not qualify | | +1 Person | +$5,380 | Call for details | **Income notes:** No substitutes like assets were typically considered; recent tax returns, pay stubs (last 3 months), or benefit statements sufficed. Program had no stated maximum age or citizenship beyond U.S. residency.[5] ## Insurance Requirements The program served **uninsured or underinsured patients**. Uninsured individuals (no prescription coverage) were primary candidates. Underinsured meant high copays/deductibles making medication unaffordable despite coverage.[1] Government insurances like **Medicare, Medicaid, or Tricare** often disqualified patients from co-pay aid but might qualify for PAP under hardship—call to confirm.[3][2] Commercial insurance patients could access co-pay help separately, but PAP was for no/low coverage.[9] ## Step-by-Step Application Process Applications were handled **by phone**—no online portal for Fareston PAP.[Program details] 1. **Contact Kyowa Kirin Cares**: Call **(866) 325-8231** (general PAP line; related programs use 833-KK-CARES/833-552-2737, M-F 8AM-8PM ET).[1][2] 2. **Speak to a Case Manager**: Explain your situation, prescription for Fareston, income, and insurance. They'll guide eligibility. 3. **Provide Information**: Share personal details (name, DOB, SSN, address), household income/size, prescription info, and doctor's contact.[5] 4. **Submit Documents**: Fax proof if requested (e.g., income docs, prescription). Use fax like 844-267-5848 for similar programs.[5] 5. **Doctor Involvement**: Your prescriber confirms medical need; they may need to sign forms.[3] 6. **Approval Notification**: Case manager calls/emails with decision. **Pro Tip:** Have all info ready; case managers offer personalized help, education, and treatment tracking.[2] ## Timeline and Delivery Processing time was not specified but typically 1-2 weeks for similar Kyowa Kirin PAPs after full submission.[5] Once approved, medication shipped free to your home or doctor's office (delivery method unspecified).[Program details][4] Refills/reauthorization involved periodic checks—call for ongoing supply.[2] ## Alternatives if Denied or Discontinued **Denial reasons:** Income too high, insured status, incomplete docs, or non-U.S. resident. Appeal by providing more proof or reapplying.[5] **Since discontinuation:**[10] - **Similar drugs**: Tamoxifen (Nolvadex PAP), raloxifene, or aromatase inhibitors (letrozole, anastrozole)—check PAN Foundation, NeedyMeds, or RxAssist.org. - **General aid**: Partnership for Prescription Assistance (PPARx.org), State Pharmaceutical Assistance Programs, or hospital charity care. - **Co-pay cards**: QuickRx Specialty for Fareston alternatives (if available).[4] - **Clinical trials**: Search ClinicalTrials.gov for breast cancer studies. - Contact Kyowa Kirin Cares at 833-552-2737 for transition support.[1] ## Disclaimer This guide is for informational purposes only and not medical/financial advice. Eligibility, availability, and terms can change; **Fareston is discontinued as of 8/31/2024**.[10] Always verify with Kyowa Kirin Cares at (866) 325-8231 or your doctor. Income guidelines approximate FPL; official verification required. Kyowa Kirin reserves rights to modify/terminate program. Consult healthcare professionals for treatment options. Word count: 1028.

Program information last verified: March 30, 2026